2020
DOI: 10.1093/nar/gkaa846
|View full text |Cite
|
Sign up to set email alerts
|

ViruSurf: an integrated database to investigate viral sequences

Abstract: ViruSurf, available at http://gmql.eu/virusurf/, is a large public database of viral sequences and integrated and curated metadata from heterogeneous sources (RefSeq, GenBank, COG-UK and NMDC); it also exposes computed nucleotide and amino acid variants, called from original sequences. A GISAID-specific ViruSurf database, available at http://gmql.eu/virusurf_gisaid/, offers a subset of these functionalities. Given the current pandemic outbreak, SARS-CoV-2 data are collected from the four sources; but ViruSurf … Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
42
1

Year Published

2020
2020
2022
2022

Publication Types

Select...
5
5

Relationship

7
3

Authors

Journals

citations
Cited by 40 publications
(43 citation statements)
references
References 24 publications
0
42
1
Order By: Relevance
“…They have created a specific resource for SARS-CoV-2 (https://www. ncbi.nlm.nih.gov/labs/virus/vssi/#/sars-cov-2), the virus responsible for COVID-19, with simple map-based visualization.A platform that provides much more data of this kind, as it integrates different data sources, is ViruSurf [52], which characterizes its sequences by using location information (e.g., continent, country, region, and municipality, when available). Other well-known players of virology bioinformatics have contributed with a geo-spatial analysis on important mutations, such as the D614G variant on the Spike protein [53]; variant distributions in the world ( [54,55]), and the COVID-19 virus mutation tracker (https://www.cbrc.kaust.edu.sa/covmt/index.php?p=maps).…”
Section: The Case Of Genomic and Clinical Geo-oedvmentioning
confidence: 99%
“…They have created a specific resource for SARS-CoV-2 (https://www. ncbi.nlm.nih.gov/labs/virus/vssi/#/sars-cov-2), the virus responsible for COVID-19, with simple map-based visualization.A platform that provides much more data of this kind, as it integrates different data sources, is ViruSurf [52], which characterizes its sequences by using location information (e.g., continent, country, region, and municipality, when available). Other well-known players of virology bioinformatics have contributed with a geo-spatial analysis on important mutations, such as the D614G variant on the Spike protein [53]; variant distributions in the world ( [54,55]), and the COVID-19 virus mutation tracker (https://www.cbrc.kaust.edu.sa/covmt/index.php?p=maps).…”
Section: The Case Of Genomic and Clinical Geo-oedvmentioning
confidence: 99%
“…ViruSurf [ 53 ] ( http://gmql.eu/virusurf/ ), dual of the human genomics search engine GenoSurf [ 54 ], is based on a conceptual model [ 31 ] that describes sequences and their metadata from their biological, technical, organizational and analytical perspectives. It provides many options for building search queries, by combining—within rich Boolean expressions—metadata attributes about viral sequences and nucleotide and amino acid variants.…”
Section: Sars-cov2 Search Systemsmentioning
confidence: 99%
“…In this respect, we underscore that any initiative aiming to apply well established standards and protocols for the sharing of SARS-CoV-2 genetic/genomic data, like for example the application or modification of the Beacon [ 130 ] protocol, as available from [ 131 ] should be fully supported by the SARS-CoV-2 research community. Finally, we stress the importance of developing highly curated resources and databases to allow the seamless integration of different types of data/and or the execution of complex queries, which could represent an important added value for data mining and meta-analyses, as exemplified by [ 132 ]. By allowing the seamless and rapid integration of different types of data and metadata, these and similar resources can—at least in part—mitigate some of the most important limitations for a rapid and widespread access to the COVID-19 data.…”
Section: Data Analysis Deposition and Accessmentioning
confidence: 99%